An Open-Label Study To Assess The Safety And Efficacy Of Treprostinil To Facilitate Liver Transplantation In Patients With Portopulmonary Hypertension (poph)

被引：0
|
作者：
Saggar, R. [1 ,5 ]
Waxman, A. B. [2 ]
Bartolome, S. [3 ]
Fisher, M. [4 ]
Mcdevitt, S. [5 ]
Zhang, L. [5 ]
Runo, J. [6 ]
Spikes, L. [7 ]
Saggar, R. [1 ,5 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] UTSW Dallas, Dallas, TX USA
[4] Emory Univ, Atlanta, GA 30322 USA
[5] United Therapeut, Res Triangle Pk, NC USA
[6] Univ Wisconsin, Madison, WI USA
[7] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4797
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long Term Outcomes in Patients Undergoing Orthotopic Liver Transplantation (OLT) for Portopulmonary Hypertension (POPH)
    Khaderi, Saira A.
    Khan, Rashid
    Safdar, Zeenat
    Blow, Benjamin J.
    Stribling, Rise
    Vierling, John M.
    Goss, John A.
    Sussman, Norman
    GASTROENTEROLOGY, 2013, 144 (05) : S998 - S998
  • [2] Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension
    Hollatz, Trina J.
    Musat, Alexandru
    Westphal, Susanne
    Decker, Catherine
    D'Alessandro, Anthony M.
    Keevil, Jon
    Li Zhanhai
    Runo, James R.
    LIVER TRANSPLANTATION, 2012, 18 (06) : 686 - 695
  • [3] Safety and efficacy of IV treprostinil for pulmonary arterial hypertension - A prospective, multicenter, open-label, 12-week trial
    Tapson, VF
    Gomberg-Maitland, M
    McLaughlin, VV
    Benza, RL
    Widlitz, AC
    Krichman, A
    Barst, RJ
    CHEST, 2006, 129 (03) : 683 - 688
  • [4] Safety of telmisartan in patients with arterial hypertension -: An open-label observational study
    Michel, MC
    Bohner, H
    Köster, J
    Schäfers, R
    Heemann, U
    DRUG SAFETY, 2004, 27 (05) : 335 - 344
  • [5] Open-label multicenter study to assess efficacy and safety of prophylactic migraine treatment with topiramate
    Santos-Zambrano, J. A.
    Rodriguez-Leyva, I
    Salinas-Estebane, R.
    Fernandez Alvarado, B.
    Nunez-Orozco, L.
    REVISTA MEXICANA DE NEUROCIENCIA, 2005, 6 (01): : 38 - 41
  • [6] OPEN-LABEL STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF FLUVASTATIN VERSUS BEZAFIBRATE FOR HYPERCHOLESTEROLEMIA
    FANGHANEL, G
    ESPINOSA, J
    OLIVARES, D
    SANCHEZ, L
    MORALES, M
    MARTINEZ, L
    MACIAS, G
    VALDES, E
    HERNANDEZ, G
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (02): : A57 - A61
  • [7] Sildenafil reduces pulmonary vascular resistance allowing for orthotopic liver transplantation in patients with portopulmonary hypertension: An open-label, single-center report
    Gough, Michael S.
    White, R. J.
    CHEST, 2006, 130 (04) : 250S - 251S
  • [8] Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study)An Open-Label Observational Study
    Jeong Bae Park
    Ki-Chul Sung
    Seok-Min Kang
    Eun Joo Cho
    American Journal of Cardiovascular Drugs, 2013, 13 : 47 - 56
  • [9] Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) An Open-Label Observational Study
    Park, Jeong Bae
    Sung, Ki-Chul
    Kang, Seok-Min
    Cho, Eun Joo
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2013, 13 (01) : 47 - 56
  • [10] BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
    Spikes, Leslie A.
    Bajwa, Abubakr A.
    Burger, Charles D.
    Desai, Sapna, V
    Eggert, Michael S.
    El-Kersh, Karim A.
    Fisher, Micah R.
    Johri, Shilpa
    Joly, Joanna M.
    Mehta, Jinesh
    Palevsky, Harold, I
    Ramani, Gautam, V
    Restrepo-Jaramillo, Ricardo
    Sahay, Sandeep
    Shah, Trushil G.
    Deng, Chunqin
    Miceli, Melissa
    Smith, Peter
    Shapiro, Shelley M.
    PULMONARY CIRCULATION, 2022, 12 (02)
12345